Nu-Med Plus (NUMD) Accounts Payables (2012 - 2025)
Nu-Med Plus (NUMD) reported Accounts Payables of $48203.0 for Q4 2025, up 12.0% on a YoY basis from $43040.0 in Q4 2024, and up 0.74% sequentially from $47847.0 in Q3 2025.
Nu-Med Plus (NUMD) Accounts Payables (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 13 years of Accounts Payables data on file, last reported at $48203.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables rose 12.0% year-over-year to $48203.0; the trailing twelve-month figure through Dec 2025 stood at $48203.0 (up 12.0% YoY), and the FY2025 full-year result was $48203.0, up 12.0% from the prior year.
- Accounts Payables climbed to $48203.0 in Q4 2025, from $47847.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $59549.0 in Q2 2022 to a low of $478.0 in Q4 2023.
- A 5-year average of $27791.9 and a median of $19197.0 in 2021 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables sank 93.35% in 2023 and jumped 8904.18% in 2024, its largest moves.
- Tracing NUMD's Accounts Payables over 5 years: stood at $27744.0 in 2021, then tumbled by 74.08% to $7192.0 in 2022, then slumped by 93.35% to $478.0 in 2023, then jumped by 8904.18% to $43040.0 in 2024, then grew by 12.0% to $48203.0 in 2025.
- Business Quant data shows NUMD's Accounts Payables at $48203.0 in Q4 2025, $47847.0 in Q3 2025, and $55204.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 3.41 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 1.18 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 2.33 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 48,203.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48,203.00 |
| Sep 30, 2025 | 47,847.00 |
| Jun 30, 2025 | 55,204.00 |
| Mar 31, 2025 | 42,995.00 |
| Dec 31, 2024 | 43,040.00 |
| Sep 30, 2024 | 19,850.00 |
| Jun 30, 2024 | 9,225.00 |
| Mar 31, 2024 | 16,457.00 |
| Dec 31, 2023 | 478.00 |
| Sep 30, 2023 | 6,585.00 |
| Jun 30, 2023 | 14,239.00 |
| Mar 31, 2023 | 13,687.00 |
| Dec 31, 2022 | 7,192.00 |
| Sep 30, 2022 | 59,366.00 |
| Jun 30, 2022 | 59,549.00 |
| Mar 31, 2022 | 46,244.00 |
| Dec 31, 2021 | 27,744.00 |
| Sep 30, 2021 | 18,544.00 |
| Jun 30, 2021 | 6,744.00 |
| Mar 31, 2021 | 12,645.00 |